Directorate Change

RNS Number : 8927J

Omega Diagnostics Group PLC

10 December 2018

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Directorate Change

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that David Evans, Chairman of the Company, has resigned from the Board and stepped down with immediate effect.  

Bill Rhodes has agreed to act as interim Chairman.  Under David's leadership, the Company had already been in the process of identifying and recruiting an additional Non-Executive Director to further strengthen the Board.  During that process, David decided that after 18 years' service, the opportunity to also bring fresh perspective from the position of Chairman would enable the Board to focus on the reshaped business and new opportunities that lie ahead.

Colin King, Chief Executive of Omega Diagnostics, commented: "The Board would like to thank David for his invaluable contribution during his 18 years of service and wish him all the best for the future."

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone]
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
	Mob: [phone]
finnCap Ltd	Tel: [phone]
Geoff Nash/James Thompson (Corporate Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

BOAEAEANESNPFAF